stoxline Quote Chart Rank Option Currency Glossary
  
Abpro Corporation (ABP)
  0 (0%)    06-28 18:07
Open:
High:
Volume: 0
  
Pre. Close:
Low:
Market Cap: 0(M)
Technical analysis
2024-03-28 4:49:55 PM
Short term     
Mid term     
Targets 6-month :  204.04 1-year :  209.69
Resists First :  174.69 Second :  179.52
Pivot price 172.58
Supports First :  166.86 Second :  138.83
MAs MA(5) :  170.23 MA(20) :  172.73
MA(100) :  149.67 MA(250) :  143.1
MACD MACD :  1.5 Signal :  2.8
%K %D K(14,3) :  11.4 D(3) :  13.9
RSI RSI(14): 49.4
52-week High :  179.52 Low :  116.41
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ BAP ] has closed above bottom band by 21.5%. Bollinger Bands are 29.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 171.47 - 172.6 172.6 - 173.63
Low: 165.2 - 166.66 166.66 - 167.98
Close: 167.19 - 169.47 169.47 - 171.54
Company Description

Headline News

Fri, 22 Sep 2023
Abpro inks SPAC deal to fund bispecific R&D years after axed IPO - Fierce Biotech

Thu, 22 Sep 2022
Abpro partners with Celltrion to advance ABP-102, a bispecific antibody for HER2+ cancers - BioWorld Online

Wed, 21 Sep 2022
Celltrion partners with Abpro of U.S. for breast cancer treatment development - Yonhap News Agency

Wed, 21 Sep 2022
Abpro inks potential $1.75B deal with Celltrion for HER2+ cancer therapy - BioWorld Online

Wed, 21 Sep 2022
Abpro Finalizes Strategic Partnership with Celltrion for Worldwide Development and Commercialization of a Cancer ... - Business Wire

Tue, 02 Feb 2021
Abpro Announces Positive Phase 1 Results Demonstrating A Favorable Safety and Pharmacokinetic Profile of ABP 300 ... - GlobeNewswire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
Sector:
Industry:
Shares Out 80 (M)
Shares Float 52 (M)
Held by Insiders 34.4 (%)
Held by Institutions 72.1 (%)
Shares Short 535 (K)
Shares Short P.Month 393 (K)
Stock Financials
EPS 16.2
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 408.32
Profit Margin 30 %
Operating Margin 36.9 %
Return on Assets (ttm) 2 %
Return on Equity (ttm) 15.8 %
Qtrly Rev. Growth 1.8 %
Gross Profit (p.s.) 0
Sales Per Share 203.44
EBITDA (p.s.) 0
Qtrly Earnings Growth -16.4 %
Operating Cash Flow 1,810 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio 10.45
PEG Ratio 8.4
Price to Book value 0.41
Price to Sales 0.83
Price to Cash Flow 7.44
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android